Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients.

Korhonen T, Kuukasjärvi T, Huhtala H, Alarmo EL, Holli K, Kallioniemi A, Pylkkänen L.

Breast. 2013 Dec;22(6):1119-24. doi: 10.1016/j.breast.2013.06.001. Epub 2013 Jul 14.

2.

Bone morphogenetic protein 4 expression in multiple normal and tumor tissues reveals its importance beyond development.

Alarmo EL, Huhtala H, Korhonen T, Pylkkänen L, Holli K, Kuukasjärvi T, Parkkila S, Kallioniemi A.

Mod Pathol. 2013 Jan;26(1):10-21. doi: 10.1038/modpathol.2012.128. Epub 2012 Aug 17.

3.

A dynamic infrared imaging-based diagnostic process for breast cancer.

Joro R, Lääperi AL, Dastidar P, Järvenpää R, Kuukasjärvi T, Toivonen T, Saaristo R, Soimakallio S.

Acta Radiol. 2009 Oct;50(8):860-9. doi: 10.1080/02841850903095377.

PMID:
19636984
4.

Dynamic infrared imaging in identification of breast cancer tissue with combined image processing and frequency analysis.

Joro R, Lääperi AL, Soimakallio S, Järvenpää R, Kuukasjärvi T, Toivonen T, Saaristo R, Dastidar P.

J Med Eng Technol. 2008 Jul-Aug;32(4):325-35. doi: 10.1080/03091900701541240.

PMID:
18666012
5.

Imaging of breast cancer with mid- and long-wave infrared camera.

Joro R, Lääperi AL, Dastidar P, Soimakallio S, Kuukasjärvi T, Toivonen T, Saaristo R, Järvenpää R.

J Med Eng Technol. 2008 May-Jun;32(3):189-97. doi: 10.1080/03091900701234358.

PMID:
18432466
6.

Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas.

Alarmo EL, Korhonen T, Kuukasjärvi T, Huhtala H, Holli K, Kallioniemi A.

Ann Oncol. 2008 Feb;19(2):308-14. Epub 2007 Sep 24.

7.

High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer.

Pärssinen J, Kuukasjärvi T, Karhu R, Kallioniemi A.

Br J Cancer. 2007 Apr 23;96(8):1258-64. Epub 2007 Mar 13.

8.

Androgen receptor amplification is associated with increased cell proliferation in prostate cancer.

Haapala K, Kuukasjärvi T, Hyytinen E, Rantala I, Helin HJ, Koivisto PA.

Hum Pathol. 2007 Mar;38(3):474-8. Epub 2007 Jan 10.

PMID:
17217995
9.

A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7.

Alarmo EL, Kuukasjärvi T, Karhu R, Kallioniemi A.

Breast Cancer Res Treat. 2007 Jun;103(2):239-46. Epub 2006 Sep 21.

PMID:
17004110
10.

Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer.

Alarmo EL, Rauta J, Kauraniemi P, Karhu R, Kuukasjärvi T, Kallioniemi A.

Genes Chromosomes Cancer. 2006 Apr;45(4):411-9.

PMID:
16419056
11.

The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours.

Rauta J, Alarmo EL, Kauraniemi P, Karhu R, Kuukasjärvi T, Kallioniemi A.

Breast Cancer Res Treat. 2006 Feb;95(3):257-63. Epub 2005 Oct 28.

PMID:
16254685
12.

Hemochromatosis gene mutations among Finnish male breast and prostate cancer patients.

Syrjäkoski K, Fredriksson H, Ikonen T, Kuukasjärvi T, Autio V, Matikainen MP, Tammela TL, Koivisto PA, Schleutker J.

Int J Cancer. 2006 Jan 15;118(2):518-20.

13.

BRCA2 mutations in 154 finnish male breast cancer patients.

Syrjäkoski K, Kuukasjärvi T, Waltering K, Haraldsson K, Auvinen A, Borg A, Kainu T, Kallioniemi OP, Koivisto PA.

Neoplasia. 2004 Sep-Oct;6(5):541-5.

14.

Frequent amplification and overexpression of CCND1 in male breast cancer.

Bärlund M, Kuukasjärvi T, Syrjäkoski K, Auvinen A, Kallioniemi A.

Int J Cancer. 2004 Oct 10;111(6):968-71.

15.

CHEK2 1100delC is not a risk factor for male breast cancer population.

Syrjäkoski K, Kuukasjärvi T, Auvinen A, Kallioniemi OP.

Int J Cancer. 2004 Jan 20;108(3):475-6.

16.
17.

Androgen receptor gene alterations in Finnish male breast cancer.

Syrjäkoski K, Hyytinen ER, Kuukasjärvi T, Auvinen A, Kallioniemi OP, Kainu T, Koivisto PA.

Breast Cancer Res Treat. 2003 Jan;77(2):167-70.

PMID:
12602915
18.

Genetic changes in familial prostate cancer by comparative genomic hybridization.

Rökman A, Koivisto PA, Matikainen MP, Kuukasjärvi T, Poutiainen M, Helin HJ, Karhu R, Kallioniemi OP, Schleutker J.

Prostate. 2001 Feb 15;46(3):233-9.

PMID:
11170152
19.

Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.

Kainu T, Juo SH, Desper R, Schaffer AA, Gillanders E, Rozenblum E, Freas-Lutz D, Weaver D, Stephan D, Bailey-Wilson J, Kallioniemi OP, Tirkkonen M, Syrjäkoski K, Kuukasjärvi T, Koivisto P, Karhu R, Holli K, Arason A, Johannesdottir G, Bergthorsson JT, Johannsdottir H, Egilsson V, Barkardottir RB, Johannsson O, Haraldsson K, Sandberg T, Holmberg E, Grönberg H, Olsson H, Borg A, Vehmanen P, Eerola H, Heikkila P, Pyrhönen S, Nevanlinna H.

Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9603-8.

20.
21.

Quality control of CGH: impact of metaphase chromosomes and the dynamic range of hybridization.

Karhu R, Kähkönen M, Kuukasjärvi T, Pennanen S, Tirkkonen M, Kallioniemi O.

Cytometry. 1997 Jul 1;28(3):198-205.

22.

Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.

Kuukasjärvi T, Karhu R, Tanner M, Kähkönen M, Schäffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP, Isola J.

Cancer Res. 1997 Apr 15;57(8):1597-604.

23.

Genetic changes in intraductal breast cancer detected by comparative genomic hybridization.

Kuukasjärvi T, Tanner M, Pennanen S, Karhu R, Kallioniemi OP, Isola J.

Am J Pathol. 1997 Apr;150(4):1465-71.

24.

Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization.

Kuukasjärvi T, Tanner M, Pennanen S, Karhu R, Visakorpi T, Isola J.

Genes Chromosomes Cancer. 1997 Feb;18(2):94-101.

PMID:
9115969
25.

Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.

Kuukasjärvi T, Kononen J, Helin H, Holli K, Isola J.

J Clin Oncol. 1996 Sep;14(9):2584-9.

PMID:
8823339
26.

Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer.

Tanner MM, Tirkkonen M, Kallioniemi A, Isola J, Kuukasjärvi T, Collins C, Kowbel D, Guan XY, Trent J, Gray JW, Meltzer P, Kallioniemi OP.

Cancer Res. 1996 Aug 1;56(15):3441-5.

Supplemental Content

Loading ...
Support Center